GHS is a clinical research site located in Danville, Pennsylvania, United States.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
GHS has participated in 1 clinical trials.
Therapeutic areas: Endometrial Cancer.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Danville
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GHS has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GHS has 1 clinical trials on record. Their work covers Endometrial Cancer.
GHS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.